Redmile Group, LLC

Shattuck Labs, Inc. · Director, 10% Owner

Redmile Group, LLC is listed in public filings as director, 10 percent owner:. This Redmile Group, LLC insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Shattuck Labs, Inc. (STTK), IGM Biosciences, Inc. (IGMS), FATE THERAPEUTICS INC (FATE), Augmedix, Inc. (AUGX), and ADC Therapeutics S.A. (ADCT). Investors use Redmile Group, LLC's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
Shattuck Labs, Inc.STTK$167k133.4k sharesSellDec 4, 2024$1.25--
Shattuck Labs, Inc.STTK$167k133.4k sharesBuyDec 4, 2024$1.25--
FATE THERAPEUTICS INCFATE$574k341.6k sharesSellDec 20, 2024$1.68--
FATE THERAPEUTICS INCFATE$669k398k sharesBuyDec 20, 2024$1.68--
ADC Therapeutics S.A.ADCT$1.1M400k sharesBuyJul 1, 2024$2.81--
ADC Therapeutics S.A.ADCT$52k25.4k sharesSellDec 4, 2024$2.07--
ADC Therapeutics S.A.ADCT$114k50k sharesBuyDec 11, 2024$2.28--
ADC Therapeutics S.A.ADCT$191k50k sharesBuyDec 11, 2024$3.81--
ADC Therapeutics S.A.ADCTDisclosure amount unavailable12.5M sharesBuyJun 11, 2025----
ADC Therapeutics S.A.ADCTDisclosure amount unavailable15.7M sharesBuyJun 11, 2025----
ADC Therapeutics S.A.ADCTDisclosure amount unavailable3.8M sharesBuyOct 27, 2025----
ADC Therapeutics S.A.ADCT$617k162.5k sharesSellApr 1, 2026$3.80--
ADC Therapeutics S.A.ADCT$707k188.4k sharesSellMar 31, 2026$3.75--
ADC Therapeutics S.A.ADCT$643k169.3k sharesSellApr 1, 2026$3.80--
ADC Therapeutics S.A.ADCT$736k196.2k sharesSellMar 31, 2026$3.75--
Redmile Group, LLC History Trades | TradingNote